The effectiveness of ketogenic diets in lowering seizure frequency among newborns.
Innovent says next-gen GLP-1 drug from Lilly beats top diabetes med in Phase 3 China study
A next-generation GLP-1 candidate from Eli Lilly has outdone an older Lilly drug in a Phase 3 trial involving Chinese patients with diabetes, Lilly partner